# Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

> **NCT03589768** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 399 (actual)

## Conditions studied

- Clostridium Difficile Immunisation
- Diphtheria
- Diphtheria Immunisation
- Pertussis
- Tetanus
- Tetanus Immunisation

## Interventions

- **BIOLOGICAL:** Tetanus and Diphtheria Toxoids Adsorbed
- **BIOLOGICAL:** Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum hydroxide

## Key facts

- **NCT ID:** NCT03589768
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-24
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 399 (ACTUAL)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589768, "Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03589768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*